Abstract OT1-02-01: A phase II study of anti-PD-1 (MK-3475) therapy in patients with metastatic inflammatory breast cancer (MIBC) or non-IBC triple negative breast cancer (non-IBC TNBC) who have achieved clinical response or stable disease to prior chemotherapy

2018 ◽  
Author(s):  
JS Willey ◽  
CA Parker ◽  
V Valero ◽  
B Lim ◽  
JM Reuben ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Response ◽  
Phase Ii ◽  
Inflammatory Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Stable Disease ◽  
Triple Negative ◽  
Phase Ii Study ◽  
Prior Chemotherapy

TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple-negative breast cancer (TNBC) brain metastases (BM).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. TPS127-TPS127 ◽  
Author(s):  
C. K. Anders ◽  
R. Nanda ◽  
M. C. Liu ◽  
K. L. Blackwell ◽  
C. H. Van Poznak ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Phase Ii ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Phase Ii Study
Sign in / Sign up

Export Citation Format

Share Document